Researchers at Temple University have discovered that microglia, the brain's immune cells, can both increase and decrease inflammation, which plays a crucial role in neurodegenerative diseases like Alzheimer's and Parkinson's. Understanding the mechanisms behind this dual behavior could lead to new therapeutic strategies aimed at preserving cognitive function and slowing disease progression.